Juan Horcajada to Adult
This is a "connection" page, showing publications Juan Horcajada has written about Adult.
Connection Strength
0.055
-
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa. BMC Infect Dis. 2017 01 05; 17(1):11.
Score: 0.012
-
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate. Int J Antimicrob Agents. 2016 Dec; 48(6):725-727.
Score: 0.011
-
Composition of the immunoglobulin G glycome associates with the severity of COVID-19. Glycobiology. 2021 05 03; 31(4):372-377.
Score: 0.004
-
Epigenome-wide association study of COVID-19 severity with respiratory failure. EBioMedicine. 2021 Apr; 66:103339.
Score: 0.004
-
Linezolid Dosing in Patients With Liver Cirrhosis: Standard Dosing Risk Toxicity. Ther Drug Monit. 2019 12; 41(6):732-739.
Score: 0.004
-
Risk of hospital readmission and associated factors after a positive sample for a multidrug-resistant microorganism. Eur J Public Health. 2019 10 01; 29(5):981-986.
Score: 0.003
-
Metabolomic Profile of ARDS by Nuclear Magnetic Resonance Spectroscopy in Patients With H1N1 Influenza Virus Pneumonia. Shock. 2018 11; 50(5):504-510.
Score: 0.003
-
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. JAMA. 2018 02 27; 319(8):788-799.
Score: 0.003
-
Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform. Electrophoresis. 2017 09; 38(18):2341-2348.
Score: 0.003
-
Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections. Antimicrob Agents Chemother. 2017 08; 61(8).
Score: 0.003
-
Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial. PLoS One. 2017; 12(4):e0173802.
Score: 0.003
-
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect Dis. 2012 Oct 05; 12:245.
Score: 0.002